Revvity Inc's Revenue in the fiscal year 2025 $ 2,856.05 millions
Revvity Inc's Revenue in the fiscal year 2024 $ 2,755.03 millions
Revvity Inc's Revenue in the fiscal year 2023 $ 2,750.57 millions
Revvity Inc's Revenue in the fiscal year 2022 $ 3,311.82 millions
Revvity Inc's Revenue in the fiscal year 2021 $ 5,067.17 millions
RVTY Revenue second quarter 2026 Y/Y Growth Comment
Revvity Inc reported Revenue growth of 1.31% year on year in the second quarter 2026, to $ 729.69 millions, this is lower than Revvity Inc's recent average Revenue growth of 8.45%.
Looking into second quarter 2026 results within Laboratory Analytical Instruments industry 12 other companies have achieved higher Revenue growth. While Revvity Inc' s Revenue increase of 1.31% ranks overall at the positon no. 2663 in the second quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Revvity Inc's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
40.52 %
2.4 %
-19.01 %
(Jan 03 2021)
RVTY's II. Quarter Q/Q Revenue Comment
Revvity Inc achieved in the II. Quarter 2026 above company average sequential Revenue growth of 2.61%, to $ 729.69 millions, from $711.12 millions in the first quarter.
Within Laboratory Analytical Instruments industry 3 other companies have achieved higher Revenue quarter on quarter growth. While Revvity Inc's Revenue growth quarter on quarter, overall rank is 1401.
Revvity Inc achieved in the II. Quarter 2026 above company average sequential Revenue growth of 2.61%, to $ 729.69 millions, from $711.12 millions in the first quarter.
Within Laboratory Analytical Instruments industry 3 other companies have achieved higher Revenue quarter on quarter growth. While Revvity Inc's Revenue growth quarter on quarter, overall rank is 1401.
Revvity Inc's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jul 05 2026)
12 Months Ending (Apr 05 2026)
12 Months Ending (Dec 28 2025)
12 Months Ending (Sep 28 2025)
12 Months Ending (Jun 29 2025)
Cumulative Revenue 12 Months Ending
$ 2,911.81
$ 2,902.41
$ 2,856.05
$ 2,813.37
$ 2,798.47
Y / Y Revenue Growth (TTM)
4.05 %
4.79 %
3.67 %
3.37 %
3.33 %
Year on Year Revenue Growth Overall
Ranking
# 2263
# 483
# 287
# 2220
# 2854
Seqeuential Revenue Change (TTM)
0.32 %
1.62 %
1.52 %
0.53 %
1.03 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 2536
# 2153
# 240
# 1519
# 1959
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jul 05 2026 period, Revvity Inc's cumulative twelve months Revenue were $ 2,912 millions, company would post below average annual Revenue growth of 1.03% year on year, if the fiscal year would end at Jul 05 2026. A slow-down in the Revvity Inc's Revenue growth from the 711.12% growth in Apr 05 2026.
In the Healthcare sector 328 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 483 to 2263.
With the quarterly Revenue reported in the Jul 05 2026 period, Revvity Inc's cumulative twelve months Revenue were $ 2,912 millions, company would post below average annual Revenue growth of -41.8% year on year, if the fiscal year would end at Jul 05 2026. A slow-down in the Revvity Inc's Revenue growth from the 711.12% growth in Apr 05 2026.
In the Healthcare sector 328 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 483 to 2263.
Companies with similar Revenue growth for the quarter ending Jul 05 2026 within Healthcare Sector
Y/Y Change %
Revenue for the quarter ending Jul 05 2026
About Revvity Inc Revenue Growth Rates (RVTY), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
